SCHEMBL7088640

SCHEMBL7088640

Cc1cnc(-c2cccc(Br)c2)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.55
RAB9A P51151 6/20 0.55
KMT2A Q03164 5/20 0.55
MEN1 O00255 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
KDM4E B2RXH2 3/20 0.55
MAPT P10636 2/20 0.55
GAA P10253 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
TP53 P04637 2/20 0.53
TSHR P16473 1/20 0.53
ALDH1A1 P00352 3/20 0.51
CYP1A2 P05177 1/20 0.51
POLB P06746 1/20 0.47
PPARG P37231 1/20 0.47
NCOA2 Q15596 1/20 0.47
NCOA1 Q15788 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31607715 1.00 NPC1 (0.55) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL12266934 0.82 RAB9A (0.56) NPC1RAB9ASMN1; SMN2KDM4EMAPT
SCHEMBL29431701 0.79 HSD17B1 (0.62) GAAMET
SCHEMBL5541340 0.79 MET (0.53) GAATP53ACHEGRM5MAOB
SCHEMBL30957335 0.79 HSD17B1 (0.62) GAAMET
SCHEMBL2288784 0.79 APP (0.50) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL2022445 0.79 MET (0.50) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL6643626 0.78 NPC1 (0.50) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL734554 0.77 TSHR (0.59) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL25245645 0.77 CYP2A6 (0.42) NPC1RAB9AKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577537-A1 SUBSTITUTED BICYCLES AS HSET INHIBITORS Merck Patent GmbH (DE) 2025-07-02 EP disclosed
WO-2024042007-A1 SUBSTITUTED BICYCLES AS HSET INHIBITORS MERCK PATENT GMBH (DE) 2024-02-29 WO disclosed
EP-1313717-A1 OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2003-05-28 EP disclosed
WO-2002016332-A1 OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS ELI LILLY AND COMPANY (US) 2002-02-28 WO disclosed